Oral antiviral medicine for the treatment of mild-to-moderate Covid-19 is likely to get approval “within days”, NDTV has reported. Dr Ram Vishwakarma, Chairman of the Covid Strategy Group, CSIR, told NDTV on Wednesday that the Merck drug Molnupiravir is likely to get the Emergency use authorisation very soon. The medicine is meant for adults who […]
\
\
